Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin R Dormuth

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Medical Care|April 15, 2009
Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medicationsColin R Dormuth, Peter Neumann, Malcolm Maclure, et al.
Pharmacoepidemiology and Drug Safety|July 4, 2019
Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British ColumbiaAnat Fisher, Greg Carney, Ken Bassett, et al.
CMAJ Open|July 27, 2019
Influence of opioid prescribing standards on drug use among patients with long-term opioid use: a longitudinal cohort studyRichard L Morrow, Ken Bassett, James M Wright, et al.
Circulation|April 11, 2007
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experimentSebastian Schneeweiss, Amanda R Patrick, Malcolm Maclure, et al.
The American Journal of Managed Care|August 10, 2007
Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionSebastian Schneeweiss, Amanda R Patrick, Malcolm Maclure, et al.
JAMA Network Open|October 2, 2023
Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 ComplicationsColin R Dormuth, Jason D Kim, Anat Fisher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2009
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part IIIMichael L Johnson, William Crown, Bradley C Martin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2012
Comparative health-care cost advantage of ipratropium over tiotropium in COPD patientsColin R Dormuth, Jesse Yamaguchi, Brett Wilmer, et al.
Plos One|June 30, 2009
Rosiglitazone and myocardial infarction in patients previously prescribed metforminColin R Dormuth, Malcolm Maclure, Greg Carney, et al.
Clinical Pharmacology and Therapeutics|April 4, 2006
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequencesSebastian Schneeweiss, Malcolm Maclure, Colin R Dormuth, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Medical Care|April 15, 2009
Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medicationsColin R Dormuth, Peter Neumann, Malcolm Maclure, et al.
Pharmacoepidemiology and Drug Safety|July 4, 2019
Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British ColumbiaAnat Fisher, Greg Carney, Ken Bassett, et al.
CMAJ Open|July 27, 2019
Influence of opioid prescribing standards on drug use among patients with long-term opioid use: a longitudinal cohort studyRichard L Morrow, Ken Bassett, James M Wright, et al.
Circulation|April 11, 2007
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experimentSebastian Schneeweiss, Amanda R Patrick, Malcolm Maclure, et al.
The American Journal of Managed Care|August 10, 2007
Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionSebastian Schneeweiss, Amanda R Patrick, Malcolm Maclure, et al.
JAMA Network Open|October 2, 2023
Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 ComplicationsColin R Dormuth, Jason D Kim, Anat Fisher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2009
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part IIIMichael L Johnson, William Crown, Bradley C Martin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2012
Comparative health-care cost advantage of ipratropium over tiotropium in COPD patientsColin R Dormuth, Jesse Yamaguchi, Brett Wilmer, et al.
Plos One|June 30, 2009
Rosiglitazone and myocardial infarction in patients previously prescribed metforminColin R Dormuth, Malcolm Maclure, Greg Carney, et al.
Clinical Pharmacology and Therapeutics|April 4, 2006
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequencesSebastian Schneeweiss, Malcolm Maclure, Colin R Dormuth, et al.
Pageof 9